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background:  Mid-wall myocardial fibrosis assessed by cardiovascular magnetic resonance imaging (CMR) predicts worse outcomes in 
patients with aortic stenosis but the clinical utility of CMR can be limited by cost, availability and patient suitability. We aimed to develop a 
clinical model of mid-wall fibrosis and to explore its prognostic value.
Methods:  One hundred and sixty four patients with aortic stenosis (70 [65,76] years old; 68% males; peak aortic velocity (Vm) 3.8±0.9 
m/s) underwent echocardiography to assess aortic stenosis severity and CMR to determine the presence of mid-wall fibrosis (CMR 
Cohort). Clinical variables associated with mid-wall fibrosis in univariate and multivariate logistic regression analyses were selected in the 
final model. We examined the prognosis associated with predicted probabilities of 98% sensitivity and 98% specificity for mid-wall fibrosis 
in a separate cohort of 121 asymptomatic patients from the Scottish Aortic Stenosis and Lipid Lowering Trial, Impact on REgression study 
(SALTIRE Cohort; 69 [62,75] years old; 70% males; Vm 3.4±0.6 m/s).
results:  Forty-nine patients in the CMR Cohort had mid-wall fibrosis. The clinical model consisted of age, sex, Vm, high-sensitivity plasma 
troponin I concentration and presence of left ventricular hypertrophy with strain on the electrocardiogram. The model demonstrated high 
discrimination and calibration for mid-wall fibrosis (c statistic 0.85 [95% CI 0.79-0.92], P<0.001; Hosmer-Lemeshow χ2 6.05, P=0.64). 
Using the predicted probabilities corresponding to 98% sensitivity and 98% specificity, 18% (n=22) and 17% (n=20) of the patients were 
classified to low- and high-risk for mid-wall myocardial fibrosis, respectively, in the SALTIRE Cohort. Over 8.3 years of follow-up, there was 
only one cardiovascular death in the lowest strata. Conversely, 67% of the cardiac deaths in the highest strata died within the first 5 years 
of follow-up (log-rank P<0.01).
conclusion:  A clinical model associated with mid-wall myocardial fibrosis holds potential in risk-stratifying patients with aortic stenosis.
